Mortality trends in multiple myeloma after the introduction of novel therapies in the United StatesMoritz Binder, Shaji Kumar, Wilson I. Gonsalves et al.|Leukemia|2021Cited by 105
Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cellsWilson I. Gonsalves, Shaji Kumar, Dragan Jevremović et al.|American Journal of Hematology|2019Cited by 63
Continued improvement in survival in multiple myeloma (MM) including high-risk patients.Bharat Nandakumar, Shaji Kumar, Moritz Binder et al.|Journal of Clinical Oncology|2019Cited by 49
Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent TherapyBharat Nandakumar, Wilson I. Gonsalves, Shaji Kumar et al.|Mayo Clinic Proceedings|2021Cited by 38
Sarcopenia identified by computed tomography imaging using a deep learning–based segmentation approach impacts survival in patients with newly diagnosed multiple myelomaBharat Nandakumar, Wilson I. Gonsalves, Francis Baffour et al.|Cancer|2022Cited by 34